14638578

Source:http://linkedlifedata.com/resource/pubmed/id/14638578

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0034897, umls-concept:C0338831, umls-concept:C0681842, umls-concept:C2004454, umls-concept:C2603343
pubmed:issue	12
pubmed:dateCreated	2003-11-25
pubmed:abstractText	Since improved prediction of illness course early in bipolar disorder is required to guide treatment planning, the authors evaluated recovery, first recurrence, and new illness onset following first hospitalization for mania.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/MH-04844, http://linkedlifedata.com/resource/pubmed/grant/MH-10948
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/14638578-14638572, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638578-15273213
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0370512
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antimanic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antipsychotic Agents
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	0002-953X
pubmed:author	pubmed-author:BaldessariniRoss JRJ, pubmed-author:Gebre-MedhinPriscillaP, pubmed-author:HennenJohnJ, pubmed-author:KhalsaHari-Mandir KaurHM, pubmed-author:SalvatorePaolaP, pubmed-author:StrakowskiStephen MSM, pubmed-author:TohenMauricioM, pubmed-author:ZarateCarlos ACAJr
pubmed:issnType	Print
pubmed:volume	160
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2099-107
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:14638578-Adolescent, pubmed-meshheading:14638578-Adult, pubmed-meshheading:14638578-Aged, pubmed-meshheading:14638578-Antimanic Agents, pubmed-meshheading:14638578-Antipsychotic Agents, pubmed-meshheading:14638578-Bipolar Disorder, pubmed-meshheading:14638578-Combined Modality Therapy, pubmed-meshheading:14638578-Comorbidity, pubmed-meshheading:14638578-Depressive Disorder, Major, pubmed-meshheading:14638578-Female, pubmed-meshheading:14638578-Follow-Up Studies, pubmed-meshheading:14638578-Humans, pubmed-meshheading:14638578-Male, pubmed-meshheading:14638578-Middle Aged, pubmed-meshheading:14638578-Outcome Assessment (Health Care), pubmed-meshheading:14638578-Patient Admission, pubmed-meshheading:14638578-Prognosis, pubmed-meshheading:14638578-Psychiatric Status Rating Scales, pubmed-meshheading:14638578-Psychotic Disorders, pubmed-meshheading:14638578-Recurrence, pubmed-meshheading:14638578-Rehabilitation, Vocational, pubmed-meshheading:14638578-Retrospective Studies, pubmed-meshheading:14638578-Socioeconomic Factors
pubmed:year	2003
pubmed:articleTitle	The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence.
pubmed:affiliation	Lilly Research Laboratories, Brougher Building, 525 South Meridian, Indianapolis, IN 46225, USA. m.tohen@lilly.com
pubmed:publicationType	Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't